Aarey Drugs & Pharmaceuticals Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd. is currently lagging behind its peers in all major financial metrics, indicating a challenging position in the Pharmaceuticals & Drugs sector. While other companies exhibit strong growth and profitability, Aarey demonstrates no revenue growth, zero profitability metrics, and a significant valuation multiple. This highlights an opportunity for improvement or a strategic pivot to enhance its market standing.

• • Aarey Drugs has no revenue or profitability metrics, posing a significant risk compared to peers.
• • Sun Pharmaceutical and Dr. Reddy's Laboratories lead in profitability and growth.
• • Cipla Ltd. and Mankind Pharma show promising growth with attractive valuation metrics.

• • Sun Pharmaceutical Industries Ltd.: Strong revenue growth of 8.42% YoY and a high ROE of 16.13%.
• • Dr. Reddy's Laboratories Ltd.: Best in class with the highest ROE (21.76%) and a strong EPS growth.
• • Mankind Pharma Ltd.: Exceptional revenue growth of 18.12% YoY and solid profitability metrics.